Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice


Terpos E., Katodritou E., de la Rubia J., Hungria V., Hulin C., Roussou M., ...More

EUROPEAN JOURNAL OF HAEMATOLOGY, vol.101, no.4, pp.556-565, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 101 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.1111/ejh.13147
  • Title of Journal : EUROPEAN JOURNAL OF HAEMATOLOGY
  • Page Numbers: pp.556-565

Abstract

Objective: The efficacy and safety of bortezomib-based therapy for relapsed/refractory multiple myeloma (RRMM) in clinical trials may differ from the oncology practice experience. The electronic VELCADE (R) OBservational Study was designed to prospectively evaluate bortezomib for multiple myeloma (MM) in real-world medical practice.